Curaleaf Partners with The Baldwin Fund for Breast Cancer Research
Curaleaf and The Baldwin Fund Unite for Breast Cancer Research
Curaleaf is celebrating a significant milestone this October as it continues its national at-register donation initiative during Breast Cancer Action Month. This initiative brings together communities and individuals to contribute towards essential breast cancer research. The funds raised will directly support The Carol M. Baldwin Breast Cancer Research Fund, widely known as The Baldwin Fund.
Continuing a Meaningful Legacy
Throughout October, customers visiting Curaleaf locations are encouraged to 'Round Up for Research' at checkout, enabling a seamless contribution to breast cancer research aimed at finding breakthroughs. This year, Curaleaf is thrilled to expand its impact across the nation through this special campaign, uniting customers around a shared goal of supporting vital research and honoring those affected by breast cancer.
The Baldwin Fund's Impact
The Baldwin Fund has an impressive history, having raised over $13 million in its fight against breast cancer for more than two decades. The organization is now embarking on a bold $50 million campaign designed to assist the Upstate Cancer Center in achieving National Cancer Institute (NCI) designation. This designation represents a high standard for innovative cancer programs and research.
The Message of Unity
Stephen Baldwin, representing The Baldwin Fund, highlights his mother's impactful mantra: "Together We Will Find a Cure." He emphasizes that this partnership provides an opportunity for individuals nationwide to contribute to cancer research. His belief in Curaleaf as a trusted and quality brand enhances the initiative's credibility and inspires customers to participate by simply rounding up their bills at the register.
Understanding the Importance of Breast Cancer Action Month
Every October, Curaleaf recognizes Breast Cancer Action Month as a vital occasion to stand united with its communities, customers, and patients. The company's chairman and CEO, Boris Jordan, asserts the importance of acknowledging individuals impacted by breast cancer. Through this partnership with The Baldwin Fund, Curaleaf invites customers to honor survivors and support their families while contributing to the research efforts aimed at eradicating this disease.
Cannabis and Cancer Care
While cannabis does not serve as a cancer treatment, many individuals living with breast cancer have reported that it assists in managing pain, anxiety, and other treatment-related side effects. Curaleaf is dedicated to offering high-quality cannabis options to patients and consumers. The company remains committed to advocating for more rigorous research on the role of cannabis in cancer care.
Participation Across Retail Locations
The at-register donation program will be available at most Curaleaf dispensaries nationwide, in accordance with state regulations. Participating states include Arizona, Connecticut, Florida, Illinois, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York, North Dakota, Pennsylvania, and Utah. This expansive reach allows for extensive community involvement in the critical mission of breast cancer research.
About Curaleaf Holdings
Curaleaf Holdings, Inc. is a leading international provider of consumer cannabis products, focused on enhancing lives through the power of the plant. Renowned for its high-growth initiatives and quality assurance, Curaleaf offers a wide array of brands catering to both medical and adult use markets. The company strives to provide exceptional service, diverse product selections, and accessibility within the cannabis space.
About The Baldwin Fund
Founded by Carol M. Baldwin in 2001, The Baldwin Fund has raised significant funds to support groundbreaking cancer research and provide hope to those affected. Guided by the belief that collaboration leads to progress, the Baldwin Fund remains committed to expanding research efforts and support for all forms of cancer.
Frequently Asked Questions
What is the goal of Curaleaf's partnership with The Baldwin Fund?
The partnership aims to support breast cancer research through at-register donations, enhancing community engagement and funding critical research initiatives.
How can customers participate in the donation initiative?
Customers can participate by rounding up their purchases at checkout during the month of October at participating Curaleaf locations.
What has been the impact of The Baldwin Fund so far?
The Baldwin Fund has raised over $13 million in its 20 years of operation, contributing significantly to breast cancer research and patient care.
Why is Breast Cancer Action Month important?
Breast Cancer Action Month serves as an opportunity to raise awareness, honor survivors, and promote funding for research dedicated to ending breast cancer.
What role does cannabis play in cancer care according to Curaleaf?
Cannabis products may help manage symptoms such as pain and anxiety in patients undergoing cancer treatment, although cannabis is not a cure for cancer.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
